Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by whatyouthinkon Aug 13, 2009 12:55pm
302 Views
Post# 16216340

RE: What is wrong with SCT?

RE: What is wrong with SCT?My opinion only.

The shares being sold today and in recent weeks were ALL purchased for less than a dime.

Profit taking is not related to company performance or even nasty rumors. Nothing is wrong.

There is absolutely no change in the SCT gameplan from what was posted months ago.

All milestones are in place;  testing is expected to be completed by the end of 2009. No more funding is required to reach the answer to the $$$ Question $$$.

As STCKGUY once said " If their SH*T works and actually repairs damaged brains" 

we are all going to be better $$$ off - after the buyout / partnership.

/

Bullboard Posts